Abbott Diabetes Care last week initiated a voluntary recall of its FreeStyle lnsulinx Blood Glucose Meters in the United States.
LifeScan initiated a voluntary recall and replacement for all of its OneTouch VerioIQ blood-glucose meters in the United States, effective immediately.
Patients diagnosed with high blood-glucose levels that cannot control the condition over time likely will develop such eye-related complications as retinopathy 10 years later, according to a report in the February issue of Archives of Ophthalmology.
It seems that MannKind has experienced a setback with a drug designed to control hyperglycemia in Type 1 and Type 2 diabetes patients.
The U.S. Patent and Trademark Office has granted a patent to the privately owned company...
Heightened blood sugar during critical illnesses could be a sign of risk for Type 2...